Skip to main navigation Skip to search Skip to main content

Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham

Jane V Loftus, Marla B Sultan, Andreas M Pleil, Macugen 1013 Study Group, Michael Larsen

33 Citations (Scopus)

Abstract

To compare vision function and self-reported quality of life (QoL) in patients with diabetic macular edema (DME) treated with intravitreous pegaptanib 0.3 mg or sham injection.
Original languageEnglish
JournalInvestigative ophthalmology & visual science
Volume52
Issue number10
Pages (from-to)7498-505
Number of pages8
ISSN0146-0404
DOIs
Publication statusPublished - 2011

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Aptamers, Nucleotide
  • Diabetic Retinopathy
  • Double-Blind Method
  • Female
  • Humans
  • Macular Edema
  • Male
  • Middle Aged
  • Quality of Life
  • Questionnaires
  • Sickness Impact Profile
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Vision, Ocular
  • Visual Acuity
  • Young Adult

Fingerprint

Dive into the research topics of 'Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham'. Together they form a unique fingerprint.

Cite this